• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?托珠单抗阻断白细胞介素-6治疗新型冠状病毒肺炎：它是否名副其实？
Pulmonology. 2021 Jan-Feb;27(1):86-87. doi: 10.1016/j.pulmoe.2020.10.004. Epub 2020 Oct 21.
2
Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study.托珠单抗阻断白细胞介素 6 对 COVID-19 患者 SARS-CoV-2 病毒动力学和抗体反应的影响：一项前瞻性队列研究。
EBioMedicine. 2020 Oct;60:102999. doi: 10.1016/j.ebiom.2020.102999. Epub 2020 Sep 16.
3
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.抗白细胞介素药物治疗重症 COVID-19 患者（COV-AID）：一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5.
4
Preemptive interleukin-6 blockade in patients with COVID-19.COVID-19 患者的预防性白细胞介素 6 阻断。
Sci Rep. 2020 Oct 8;10(1):16826. doi: 10.1038/s41598-020-74001-3.
5
Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma.白细胞介素6阻断疗法治疗两名多发性骨髓瘤患者的重症新型冠状病毒肺炎
Br J Haematol. 2020 Jul;190(1):e9-e11. doi: 10.1111/bjh.16787. Epub 2020 May 18.
6
Vascular microthrombosis associated with increased interleukin-6. A severe acute respiratory distress syndrome in COVID-19 patients treated with tocilizumab.与白细胞介素-6升高相关的血管微血栓形成。在接受托珠单抗治疗的COVID-19患者中出现的严重急性呼吸窘迫综合征。
Adv Respir Med. 2020;88(5):468-469. doi: 10.5603/ARM.a2020.0123.
7
Tocilizumab-A beacon of hope in the management of severe COVID-19?托珠单抗——重症新冠病毒肺炎治疗中的希望之光？
J Med Virol. 2021 Feb;93(2):675-677. doi: 10.1002/jmv.26466. Epub 2020 Sep 29.
8
Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.托珠单抗治疗新型冠状病毒肺炎移植受者后的白细胞介素6水平
Kidney Int. 2020 Oct;98(4):1054. doi: 10.1016/j.kint.2020.06.025. Epub 2020 Jul 8.
9
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease.托珠单抗治疗 COVID-19 患者：新型疾病推荐药物。
Int Immunopharmacol. 2020 Dec;89(Pt A):107018. doi: 10.1016/j.intimp.2020.107018. Epub 2020 Sep 16.
10
Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.托珠单抗治疗细胞因子风暴综合征的 SARS-CoV-2 患者：一项叙述性综述。
Rev Recent Clin Trials. 2021;16(2):138-145. doi: 10.2174/1574887115666200917110954.

引用本文的文献

1
Trajectories and predictive significance of inflammatory parameters for clinical outcome in COVID-19 patients treated with tocilizumab.托珠单抗治疗的COVID-19患者炎症参数的轨迹及其对临床结局的预测意义
Infection. 2025 Feb;53(1):339-348. doi: 10.1007/s15010-024-02375-x. Epub 2024 Aug 29.
2
Immunomodulatory approaches in managing lung inflammation in COVID-19: A double-edge sword.管理 COVID-19 肺部炎症的免疫调节方法：一把双刃剑。
Immun Inflamm Dis. 2023 Sep;11(9):e1020. doi: 10.1002/iid3.1020.
3
Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors' reply.托珠单抗用于新型冠状病毒肺炎的理论依据与证据：一项系统评价。作者回复
Pulmonology. 2021 Jan-Feb;27(1):87-88. doi: 10.1016/j.pulmoe.2020.10.003. Epub 2020 Oct 21.

本文引用的文献

1
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.托珠单抗治疗重症 COVID-19 肺炎住院患者。
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
2
Is IL-6 the Right Target in COVID-19 Severe Pneumonia?白细胞介素-6是新冠重症肺炎的正确治疗靶点吗？
Am J Respir Crit Care Med. 2021 Jan 1;203(1):139-140. doi: 10.1164/rccm.202007-2924LE.
3
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study.重症监护病房中新冠肺炎患者使用托珠单抗的多中心观察性研究。
Lancet Rheumatol. 2020 Oct;2(10):e603-e612. doi: 10.1016/S2665-9913(20)30277-0. Epub 2020 Aug 14.
4
Rationale and evidence on the use of tocilizumab in COVID-19: a systematic review.托珠单抗在 COVID-19 中的应用的原理和证据：系统评价。
Pulmonology. 2021 Jan-Feb;27(1):52-66. doi: 10.1016/j.pulmoe.2020.07.003. Epub 2020 Jul 20.

Interleukin-6 blockade with tocilizumab in COVID-19: Does it live up to its hype?

作者信息

Kow C S, Hasan S S

机构信息

School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.

Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

出版信息

Pulmonology. 2021 Jan-Feb;27(1):86-87. doi: 10.1016/j.pulmoe.2020.10.004. Epub 2020 Oct 21.

DOI:10.1016/j.pulmoe.2020.10.004
PMID:33158786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7577654/
Abstract
摘要